Literature DB >> 15543217

Gene-gene interaction between PPAR gamma 2 and ADR beta 3 increases obesity risk in children and adolescents.

M C Ochoa1, A Marti, C Azcona, M Chueca, M Oyarzábal, R Pelach, A Patiño, M J Moreno-Aliaga, M A Martínez-González, J A Martínez.   

Abstract

AIMS: Multiple genes are likely to be involved in obesity and these genes may interact with environmental factors to influence obesity risk. Our aim was to explore the synergistic contribution of the two polymorphisms: Pro12Ala of the PPAR gamma 2 gene and Trp64Arg of the ADR beta 3 gene to obesity risk in a Spanish children and adolescent population.
METHODS: We designed a sex- and age-matched case-control study. Participants were 185 obese and 185 control children (aged 5-18 y) from the Navarra region, recruited through Departments of Pediatrics (Hospital Virgen del Camino, Navarra University Clinic and several Primary Health Centers). The obesity criterion (case definition) was BMI above the 97th percentile according to Spanish BMI reference data for age and gender. Anthropometric parameters were measured by standard protocols. The genotype was assessed by PCR-RFLP after digestion with BstUI for PPAR gamma 2 mutation and BstNI for ADR beta 3 variants. Face-to-face interviews were conducted to assess the physical activity. Using a validated physical activity questionnaire, we computed an activity metabolic equivalent index (METs h/week), which represents the physical exercise during the week for each participant. Statistical analysis was performed by conditional logistic regression, taking into account the matching between cases and controls.
RESULTS: Carriers of the polymorphism Pro12Ala of the PPAR gamma 2 gene had a significantly higher obesity risk than noncarriers (odds ratio (OR)=2.18, 95% CI=1.09-4.36) when we adjusted for sex, age and physical activity. Moreover, the risk of obesity was higher (OR=2.59, 95% CI=1.17-5.34) when family history of obesity was also taken into account in the model. The OR for obesity linked to both polymorphisms (PPAR gamma 2 and ADR beta 3) was 5.30 (95% CI=1.08-25.97) when we adjusted for sex, age and physical activity. After adjustment for family history of obesity, the OR for carriers of both polymorphisms was 19.5 (95% CI=2.43-146.8).
CONCLUSIONS: A synergistic effect between polymorphism Pro12Ala of the PPAR gamma 2 gene and Trp64Arg of the ADR beta 3 gene for obesity risk was found in a case-control study including children and adolescents.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15543217     DOI: 10.1038/sj.ijo.0802803

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  16 in total

1.  Interaction of occupational and personal risk factors in workforce health and safety.

Authors:  Paul A Schulte; Sudha Pandalai; Victoria Wulsin; HeeKyoung Chun
Journal:  Am J Public Health       Date:  2011-11-28       Impact factor: 9.308

2.  Gene-based interaction analysis by incorporating external linkage disequilibrium information.

Authors:  Jing He; Kai Wang; Andrew C Edmondson; Daniel J Rader; Chun Li; Mingyao Li
Journal:  Eur J Hum Genet       Date:  2010-10-06       Impact factor: 4.246

3.  Identifying gene-gene interactions using penalized tensor regression.

Authors:  Mengyun Wu; Jian Huang; Shuangge Ma
Journal:  Stat Med       Date:  2017-10-16       Impact factor: 2.373

4.  Penalized integrative semiparametric interaction analysis for multiple genetic datasets.

Authors:  Yang Li; Rong Li; Cunjie Lin; Yichen Qin; Shuangge Ma
Journal:  Stat Med       Date:  2019-04-16       Impact factor: 2.373

5.  Association between PPAR-γ2 Pro12Ala polymorphism and obesity: a meta-analysis.

Authors:  Ying-Shui Yao; Jie Li; Yue-Long Jin; Yan Chen; Lian-Ping He
Journal:  Mol Biol Rep       Date:  2014-12-13       Impact factor: 2.316

6.  Roles of beta2- and beta3-adrenoceptor polymorphisms in hypertension and metabolic syndrome.

Authors:  Kazuko Masuo
Journal:  Int J Hypertens       Date:  2010-10-21       Impact factor: 2.420

7.  Peroxisome proliferator-activated receptor γ polymorphism Pro12Ala Is associated with nephropathy in type 2 diabetes: evidence from meta-analysis of 18 studies.

Authors:  Hui Zhang; Shimiao Zhu; Jing Chen; Yang Tang; Hailong Hu; Viswanathan Mohan; Radha Venkatesan; Jianmin Wang; Haiping Chen
Journal:  Diabetes Care       Date:  2012-06       Impact factor: 19.112

8.  PPARγ Pro12Ala and ACE ID polymorphisms are associated with BMI and fat distribution, but not metabolic syndrome.

Authors:  Angela Passaro; Edoardo Dalla Nora; Caterina Marcello; Francesca Di Vece; Mario Luca Morieri; Juana M Sanz; Cristina Bosi; Renato Fellin; Giovanni Zuliani
Journal:  Cardiovasc Diabetol       Date:  2011-12-14       Impact factor: 9.951

9.  Interaction between Calpain 5, Peroxisome proliferator-activated receptor-gamma and Peroxisome proliferator-activated receptor-delta genes: a polygenic approach to obesity.

Authors:  María E Sáez; Antonio Grilo; Francisco J Morón; Luis Manzano; María T Martínez-Larrad; Antonio González-Pérez; Javier Serrano-Hernando; Agustín Ruiz; Reposo Ramírez-Lorca; Manuel Serrano-Ríos
Journal:  Cardiovasc Diabetol       Date:  2008-07-25       Impact factor: 9.951

10.  PPARγ2 polymorphism and human health.

Authors:  Weimin He
Journal:  PPAR Res       Date:  2009-04-16       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.